Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. Mai 2019 16:03 ET | Quelle: Concentric Analgesics, Inc.

Concentric Analgesics Raises $76 Million in Series B Financing

Proceeds will advance development of CA-008, a potential first-in-class long-lasting non-opioid therapeutic for the treatment of post-surgical pain Raise also supports continued development of...
04. März 2019 08:00 ET | Quelle: Concentric Analgesics, Inc.

Concentric Analgesics to Present at the Cowen 39th Annual Healthcare Conference

SAN FRANCISCO, March 04, 2019 (GLOBE NEWSWIRE) -- Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, non-opioid pain...
08. November 2018 08:00 ET | Quelle: Concentric Analgesics, Inc.

Concentric Analgesics Announces Positive Topline Results from Phase 2 Clinical Trial of CA-008 in Bunionectomy

Clinically Meaningful Reductions in Pain Lasting Through One Week vs. Active Control 50% Reduction in Opioid Use with 26% of Patients Opioid Free For 28 Days SAN FRANCISCO, Nov. 08, 2018 (GLOBE...